Actinium Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Stocks
7AY1
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7080 EUR | -0.56% |
|
-7.21% | -39.80% |
| Market Cap | 2.55Cr 2.21Cr 2.06Cr 1.9Cr 3.58Cr 242.71Cr 3.64Cr 24Cr 9.53Cr 120.98Cr 9.56Cr 9.35Cr 400.64Cr | P/E 2026 * |
-0.96x | P/E 2027 * | -1.45x |
|---|---|---|---|---|---|
| Enterprise Value | 2.55Cr 2.21Cr 2.06Cr 1.9Cr 3.58Cr 242.71Cr 3.64Cr 24Cr 9.53Cr 120.98Cr 9.56Cr 9.35Cr 400.64Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 1.97x |
| Free-Float |
97.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.56% | ||
| 1 week | -7.21% | ||
| Current month | -0.56% | ||
| 1 month | -15.71% | ||
| 3 months | -26.40% | ||
| 6 months | -25.08% | ||
| Current year | -39.80% |
| 1 week | 0.71 |  | 0.74 |
| 1 month | 0.71 | | 0.9 |
| Current year | 0.71 | | 1.25 |
| 1 year | 0.71 | | 1.5 |
| 3 years | 0.71 | | 9.8 |
| 5 years | 0.71 | | 19.8 |
| 10 years | 0.71 | | 57.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 62 | 09/06/2017 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2026 |
Adeela Kamal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Nicholson
BRD | Director/Board Member | 71 | 01/01/2008 |
Sandesh Seth
CHM | Chairman | 62 | 01/10/2013 |
| Director/Board Member | 68 | 08/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | -7.21% | - | - | 2.63Cr | |
| +0.05% | +2.80% | +38.17% | +74.12% | 5.65TCr | |
| -3.06% | -10.22% | +23.62% | +58.59% | 5.36TCr | |
| +1.84% | +3.27% | -14.06% | -12.13% | 2.29TCr | |
| -0.15% | -7.92% | -9.42% | +352.23% | 2.14TCr | |
| +0.15% | -0.77% | +23.76% | -11.52% | 2.03TCr | |
| -0.67% | -1.73% | +33.09% | -31.09% | 1.76TCr | |
| -1.45% | -7.24% | +17.67% | +563.14% | 1.47TCr | |
| +9.91% | +2.64% | +188.84% | +326.19% | 1.35TCr | |
| +3.83% | -0.56% | +47.77% | +170.70% | 1.33TCr | |
| Average | +0.99% | -1.88% | +38.83% | +165.58% | 2.6TCr | |
| Weighted average by Cap. | +0.14% | -1.70% | +31.71% | +123.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 1.29Cr 1.12Cr 1.05Cr 96.25L 1.82Cr 123.23Cr 1.85Cr 12Cr 4.84Cr 61Cr 4.85Cr 4.75Cr 203.41Cr |
| Net income | -2.85Cr -2.48Cr -2.31Cr -2.12Cr -4Cr -271.68Cr -4.07Cr -27Cr -11Cr -135.42Cr -11Cr -10Cr -448.46Cr | -2.33Cr -2.02Cr -1.88Cr -1.73Cr -3.27Cr -221.81Cr -3.32Cr -22Cr -8.71Cr -110.56Cr -8.74Cr -8.55Cr -366.13Cr |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 03/26/03 | €0.7080 | -0.56% |
| 31/26/31 | €0.7120 | -0.14% |
| 30/26/30 | €0.7130 | -3.65% |
| 29/26/29 | €0.7400 | +0.82% |
| 28/26/28 | €0.7340 | -0.94% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
- 7AY1 Stock
Select your edition
All financial news and data tailored to specific country editions
